Dmitriy A. Derkatch

Dmitriy A. Derkatch

Auto-generated profile, based on publicly available information

Dmitriy A. Derkatch

Endocrinology Research Centre

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 December 2020 in Problems of Endocrinology
Verified
Journal Article
Closed access
PDF file
ACA. Chevais
A. Chevais
LULiliia Urusova
Liliia Urusova
NKN. S. Kuznetzov
N. S. Kuznetzov
DDD. А. Derkatch
D. А. Derkatch
Marina YukinaMarina Yukina
Marina Yukina
МЮМ. Ю. Юкина
М. Ю. Юкина
Bilateral macronodular adrenal hyperplasia (BMAH) is a rare cause of Cushing’s syndrome. In this case cortisol production can be regulated by both genetic factors and various molecular mechanisms. The presence of aberrant or overexpression of eutopic receptors on the membrane of adrenal cortex may lead to activation of cAMP/PKA signaling pathways and consequently, pathological stimulation of steroidogenesis. Since proving the effectiveness of unilateral adrenalectomy in BMAH by achievement of stable remission, preoperative clinical and laboratory tests (ligand-induced tests) are no longer of relevant. Nevertheless, in the absence of normalization of the level of cortisol in the postoperative period or its recurrence, subsequent specific targeted medical options can be offered only if expression/hyperexpression predominance of one or another receptor. Their detection becomes possible using more reliable diagnostic methods such as polymerase chain reaction (PCR) and immunohistochemical studies (IHC) than clinical laboratory tests. At the moment, PCR has gained a wider application. This article summarizes data on the use of immunohistochemical study in BMAH.

11 March 2023 in Endocrine Surgery
Verified
Journal Article
Open access
PDF file
ACA. Chevais
A. Chevais
AEA. R. Elfimova
A. R. Elfimova
DDD. A. Derkatch
D. A. Derkatch
ARA. N. Romanova
A. N. Romanova
AEA. K. Ebzeeva
A. K. Ebzeeva
АША. Шевэ
А. Шевэ
BACKGROUND: To date, surgical treatment is an effective treatment of hypercortisolism in primary bilateral macronodular hyperplasia (PBMAH). Due to the bilateral lesion, the most common treatment in Russia is the bilateral adrenalectomy, which requires the appointment of hormone replacement therapy. The results of various studies on the effectiveness of unilateral adrenalectomy (UA) in PBMAH are rather discordant.AIM: The objective of the study was to assess the outcomes of UA in patients with PBMAH, accompanied by mild autonomous cortisol excess (MACE) or overt Cushing’s syndrome (CS).MATERIALS AND METHODS: 44 patients with PBMAH and a manifest form of CS (n=21) MACE with comorbid conditions (n=23) underwent UA in the surgical department of the Endocrinology Research Centre. The dynamics of laboratory parameters (cortisol after overnight dexamethasone suppression test (cortisol ONDST) urinary free cortisol (СКМ), ACTH), as well as the course of comorbid diseases (diabetes mellitus, arterial hypertension (AH), metabolic disorders) were assessed before and after 6 months of surgical intervention. The cut-off level of blood cortisol (8:00–9:00) during the first day after OA was determined as a predictor of the development of adrenal insufficiency (AI) in the early postoperative period.RESULTS: 6 months after OA, laboratory parameters improved in 40/44 (91%, 95% CI: 78%-97%) cases: cortisol ONDST decreased from 466 [173; 652] to 86 [61; 149] nmol/l, p=<0.01, СКМ dropped from 840 [468; 1892] to 267 [204; 432] nmol/day, p=<0.01), while ACTH increased gradually from 1 [1; 2.1] to 8.3 [2.6; 15.0] pg/ml, p=<0.01), which indicates the effectiveness of UA. Statistically significant changes in BMI were also obtained (before UA — 30.8 [27.5; 34.4], after — 28.5 [23.9; 32.2] kg/m2 (p <0.01)). When analyzing the long-term outcomes of UA on carbohydrate metabolism, a decrease in the level of HbA1c from 7.0 [6.3; 7.7] to 6.0 [5.6; 6.7] %, (p<0.01) was observed. Further, there was an improvement in the course of AH. After UA, antihypertensive therapy was completely discontinued in 27.7% of cases, and a reduction in the number of antihypertensive drugs was carried out in 44.4%. The level of cortisol in the early postoperative period less than 325 nmol/l was the strongest factor predicting the potential adrenal failure (AUC=0.96).CONCLUSION: UA can be recommended as the first line treatment of PBMAH with CS due to the high probability of longterm remission of hypercortisolism and improvement in the course of comorbid diseases.

17 August 2020 in Endocrine Surgery
Verified
Journal Article
Open access
PDF file
NMNatalia V. Molashenko
Natalia V. Molashenko
DBDiana M. Babaeva
Diana M. Babaeva
DDDmitriy A. Derkatch
Dmitriy A. Derkatch
VVVictoriya P. Vladimirova
Victoriya P. Vladimirova
TSTatiana V. Soldatova
Tatiana V. Soldatova
ВВВоронцов Александр Валерьевич
Воронцов Александр Валерьевич
The article describes the clinical case of diagnosing and choosing the tactics for treating ovarian adrenal rest tumors (OART) in a patient with a salt-wasting form of congenital adrenal hyperplasia (CAH). There are only several clinical cases descriptions of OART in the world literature. At present, the tactics of observation and treatment of the ovarian adrenal rest tumors has not been developed. In each case, individual tactics are chosen. The main predisposing factor to the occurrence of OART is considered to be long periods of decompensation of CAH. ACTH stimulates the hyperplasia and hypertrophy of the residual adrenal tissue in the ovaries and secondary tumors develop. The instrumental methods that allow to diagnose OART include ultrasound, MRI of the pelvic organs, PET with 18FDG. The tactics of treating OART, in contrast to the testicular adrenal rest tumors in men (TART), according to world literature are mainly surgical. Organ-preserving operations were performed, as well as the removal of tumors along with the ovary. Cases of a combination of adenocarcinoma and CAH are also described. Each new case of OART is unique and with the accumulation of international experience, a consensus will be developed.

19 October 2021 in Endocrine Surgery
Verified
Journal Article
Open access
PDF file
ACA. Chevais
A. Chevais
DBDmitry G. Beltsevich
Dmitry G. Beltsevich
AAA. Yu. Abrosimov
A. Yu. Abrosimov
DDD. A. Derkatch
D. A. Derkatch
ALA. A. Lazareva
A. A. Lazareva
Micronodular adrenal hyperplasia is a rare cause of ACTH-independent Cushing syndrome. It can be divided into two entities: primary pigmented nodular adrenocortical disease (PPNAD) and non-pigmented micronodular adrenocortical disease, among which familial and sporadic forms are distinguished. The most common is the genetically determined familial form PPNAD, as one of the components of Carney complex. The vast majority of patients have identifiable pathogenic variants in the PRKAR1A gene. In addition to the PRKAR1A gene mutations, inactivating mutations in the genes encoding phosphodiesterases (PDE11A4 and PDE8B), as well as PRKACA gene amplification, have been described in individuals with isolated forms. Despite the relative antiquity of the description of micronodular adrenal hyperplasia and the Carney comlex, a detailed study of pathophysiological mechanisms, genetic and clinical aspects of this pathology, nowadays, clinicians continue to face «atypical» cases. Thus, the nature of this disease is not well understood and requires further research. This review presents the accumulated data on micronodular adrenal hyperplasia, genetics aspects, and also describes 2 unique clinical cases of isolated PPNAD with unilateral adrenalectomy results.

19 March 2025 in Russian Journal of Preventive Medicine
Verified
Journal Article
Closed access
LDLarisa K Dzeranova
Larisa K Dzeranova
EPEKATERINA PIGAROVA
EKATERINA PIGAROVA
MPM.A. Perepelova
M.A. Perepelova
KIK.V. Ivashchenko
K.V. Ivashchenko
KTK.M. Tataeva
K.M. Tataeva
NPN.M. Platonova
N.M. Platonova
Pheochromocytoma is a rare neuroendocrine tumor consisting of chromaffin cells of the adrenal medullary layer, a special case of sympathetic paraganglioma. The classic clinical sign of pheochromocytoma is a sympathoadrenal crisis characterized by attacks of a significant increase in blood pressure, tachycardia, severe sweating, and vasomotor reactions. This article describes a rare case of pheochromocytoma with a non-classical onset of the disease with a combination of nonspecific symptoms and no hypertension at the onset of the disease. The patient, 57 years old, presented in the National Medical Research Center for Endocrinology with general weakness, fatigue, anxiety attacks up to 2—3 times a day, and increased sweating. Previously, these symptoms were attributed to the persistence of menopausal syndrome; also, a mass in the adrenal gland of 40×37×39 mm was identified with a heterogeneous structure, a density in the native phase from 26 to 39 HU, and an absolute washout rate of 51%. With additional examination, the results of laboratory tests (metanephrine in daily urine 629 μg/day, normetanephrine 1331 μg/day) combined with modern imaging methods contributed to the diagnosis of pheochromocytoma followed by the effective surgical treatment. Morphological and immunohistochemical data corresponded to pheochromocytoma of the left adrenal gland, PASS 2 score. After surgical treatment, the patient achieved normotension without additional drug therapy. Vasomotor symptoms typical of pheochromocytoma may be overlooked by clinicians, especially in cases without hypertension or with comorbidities with similar clinical manifestations, as in the presented clinical case. It supports excluding the hyperproduction of catecholamines in cases of adrenal masses with indeterminate and malignant computed tomography phenotypes, regardless of the presence of symptoms.